Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Weihai Baihe Biology Technological Co does not have enough data to calculate 10-Year ROIIC %.
Weihai Baihe Biology Technological Co (SHSE:603102) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Weihai Baihe Biology Technological Co 10-Year ROIIC % Related Terms
Weihai Baihe Biology Technological Co 10-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weihai Baihe Biology Technological Co 10-Year ROIIC % Chart
SHSE:603102 vs KHC, GIS: 10-Year ROIIC % Comparison
For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weihai Baihe Biology Technological Co 10-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Weihai Baihe Biology Technological Co's 10-Year ROIIC % falls into.
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( 128.4346175 (Dec. 2024) - (Dec. 2014) )
/
( 538.413 (Dec. 2024) - (Dec. 2014) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Weihai Baihe Biology Technological Co (SHSE:603102) has a 10-Year ROIIC % of 45.34 as of Dec. 2024. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Weihai Baihe Biology Technological Co and its competitors. According to the industry distribution chart, Weihai Baihe Biology Technological Co ranks #140 out of 1591 companies in the Consumer Packaged Goods industry, placing it in the top 8.8%.
Is Weihai Baihe Biology Technological Co's 10-Year ROIIC % too high?
Weihai Baihe Biology Technological Co's current 10-Year ROIIC % is 45.34. The Consumer Packaged Goods industry median 10-Year ROIIC % is 4.27. Weihai Baihe Biology Technological Co's value of 45.34 is 961.8% above this industry median. Based on the distribution chart, Weihai Baihe Biology Technological Co ranks #140 out of 1591 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Weihai Baihe Biology Technological Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Weihai Baihe Biology Technological Co's 10-Year ROIIC % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Weihai Baihe Biology Technological Co ranks #140 out of 1591 companies for 10-Year ROIIC %. This places Weihai Baihe Biology Technological Co in the top 9% of its industry — outperforming the majority of peers. The industry median 10-Year ROIIC % is 4.27. Weihai Baihe Biology Technological Co's value of 45.34 is 961.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Consumer Packaged Goods company?
The median 10-Year ROIIC % among Consumer Packaged Goods companies is 4.27, based on 1,591 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weihai Baihe Biology Technological Co's current 10-Year ROIIC % of 45.34 is 961.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Weihai Baihe Biology Technological Co and its competitors. For the Consumer Packaged Goods industry, the median 10-Year ROIIC % is 4.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weihai Baihe Biology Technological Co's current 10-Year ROIIC % is 45.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weihai Baihe Biology Technological Co stock overvalued right now?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co (SHSE:603102) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥47.20, compared to a current price of ¥34.99 — trading 25.9% below its estimated fair value. The current 10-Year ROIIC % is 45.34 and 961.8% above the Consumer Packaged Goods industry median of 4.27. Weihai Baihe Biology Technological Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Weihai Baihe Biology Technological Co (SHSE:603102), the current 10-Year ROIIC % is 45.34 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Weihai Baihe Biology Technological Co (SHSE:603102) Overvalued in 2026?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co stock appears to be undervalued.
The current stock price of ¥34.99 is trading 25.9% below its estimated GF Value™ of ¥47.20.
GuruFocus considers Weihai Baihe Biology Technological Co to be Modestly Undervalued.
Key valuation signals for SHSE:603102:
10-Year ROIIC %: 45.34
GF Value™: ¥47.20 vs. price of ¥34.99 (25.9% below fair value)
Industry Position: 961.8% above the Consumer Packaged Goods median (#140 of 1591)
No single metric tells the full story. See the SHSE:603102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603102 has been successfully added to your 
